Drug
Fruquintinib Paclitaxel
Fruquintinib Paclitaxel: highest development phase Phase 3, developed by United Therapeutics. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- United Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| fruquintinib +paclitaxel NCT03223376 | Phase 3 | Advanced Gastric Cancer |
| fruquintinib+paclitaxel NCT02415023 | Phase 1/2 | Gastric Cancer |
Latest
No recent events.
Follow Fruquintinib Paclitaxel on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.